LAVA THERAPEUTICS NV share price logo

LAVA THERAPEUTICS NV

NASDAQ: LVTX

$1.77

-0.04

(-2.21%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 20 Nov 2025

LAVA THERAPEUTICS NV Stock Performance

as on November 21, 2025 at 7:59 am IST

  • Day's Low

    Day's High

    $1.62
    $1.82
    downward going graph

    8.47%

    Downside

    2.82%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.40
    $1.83
    downward going graph

    20.90%

    Downside

    3.11%

    Upside

    downward going graph

LAVA THERAPEUTICS NV share price movements today

Previous Close
$1.81
Open
$1.82
Volume
1.6M
Day's Low - High
$1.62 - $1.82
52 Week Low - High
$1.40 - $1.83

LAVA THERAPEUTICS NV Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

LAVA THERAPEUTICS NV Stock Fundamentals & Key Indicators

Check LAVA THERAPEUTICS NV market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

LAVA THERAPEUTICS NV vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of LAVA THERAPEUTICS NV with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
LAVA THERAPEUTICS NV image
LAVA THERAPEUTICS NV
BUY$-NANA0.00%NA
BUY$21.4B285.74%NA-144.44%NA
BUY$29.5B12.18%38.4516.13%NA
BUY$119.5B138.55%27.9535.51%NA
BUY$78.2B24.52%18.7827.87%0.48%

Analyst Recommendation on LAVA THERAPEUTICS NV Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for LAVA THERAPEUTICS NV. Average target price of $1.37

LAVA THERAPEUTICS NV Share Price Target

Get share price movements and forecasts by analysts on LAVA THERAPEUTICS NV.

What analysts predicted

-29.2%DOWNSIDE

Target Price

$1.37

Current Price

$1.77

Analyzed by

11 Analysts

Target

$1.37

LAVA THERAPEUTICS NV target price $1.37, a slight downside of -29.2% compared to current price of $1.77. According to 11 analysts rating.

LAVA THERAPEUTICS NV Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
5
0
0
7
0
-
4
-
-
-
Gross Profit
2
0
0
7
0
0
-19
0
0
-
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-13
-9
-7
0
-8
-13
-3
-3
-8
-7
Net Profit Margin
-247.13%
-16671.70%
-1840.79%
-8.70%
-3640.37%
0.00%
-79.56%
0.00%
0.00%
0.00%

LAVA THERAPEUTICS NV Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
4
5
20
7
11
Gross Profit
-9
-14
5
20
3
11
Operating Income
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
Net Income
-10
-19
-51
-33
-45
-25
Net Profit Margin
0.00%
-425.06%
-906.94%
-164.55%
-618.57%
-209.60%

Global Institutional Holdings in LAVA THERAPEUTICS NV

Funds
Holdings
Redmile Group, LLC
7.89%
BML Capital Management LLC
7.49%
Sanofi
7.3%
Merck & Co Inc
4.37%
Bruce & Co Inc
1.98%

Insights on LAVA THERAPEUTICS NV

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -8.63M → -7.18M (in $), with an average increase of 20.2% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 227.99K → 4.99M (in $), with an average increase of 95.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LVTX stock has moved up by 4.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 982.0% return, outperforming this stock by 1051.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 171.7% return, outperforming this stock by 163.0%

About LAVA THERAPEUTICS NV


OrganisationLAVA THERAPEUTICS NV
E-voting on sharesClick here to vote

FAQs

What is LAVA THERAPEUTICS NV share price today?

LAVA THERAPEUTICS NV share price today is $1.77 as on at the close of the market. LAVA THERAPEUTICS NV share today touched a day high of $1.82 and a low of $1.62.

What is the 52 week high and 52 week low for LAVA THERAPEUTICS NV share?

LAVA THERAPEUTICS NV share touched a 52 week high of $1.83 on and a 52 week low of $1.40 on . LAVA THERAPEUTICS NV stock price today i.e. is closed at $1.77,which is 3.01% down from its 52 week high and 26.43% up from its 52 week low.

How to invest in LAVA THERAPEUTICS NV Stock (LVTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for LAVA THERAPEUTICS NV on INDmoney app. Click on Buy button. You can invest as low as $1.5 in LAVA THERAPEUTICS NV Shares that will get you 0.8475 shares as per LAVA THERAPEUTICS NV share price of $1.77 per share as on November 21, 2025 at 2:29 am IST.

What is the minimum amount required to buy LAVA THERAPEUTICS NV Stock (LVTX) from India?

Indian investors can start investing in LAVA THERAPEUTICS NV (LVTX) shares with as little as ₹95.12 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹951.20 in LAVA THERAPEUTICS NV stock (as per the Rupee-Dollar exchange rate as on ). Based on LAVA THERAPEUTICS NV share’s latest price of $1.77 as on November 21, 2025 at 2:29 am IST, you will get 5.6497 shares of LAVA THERAPEUTICS NV. Learn more about fractional shares .